Exploring olive oil compounds oleuropein and hydroxytyrosol as potential treatments for neuroblastoma

FHS
March 15, 2024
12:15 pm

The therapeutic potential of oleuropein (OLE) and hydroxytyrosol (HT) from olive oil.

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more

October 24, 2023

Updated: As sales continue to slide, Catalent reaches deal with activist to add board seats and conduct review

As it deals with major declines in revenue, the replacement of top managers and issues with its manufacturing facilities, Catalent said it has reached an

August 30, 2023

Drug firms test medicines to halt Alzheimer’s before symptoms appear

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft. The first was her

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.